The Bioactivity of Xylene, Pyridine, and Pyrazole Aza Macrocycles against Three Representative Leishmania Species

Pharmaceutics. 2023 Mar 20;15(3):992. doi: 10.3390/pharmaceutics15030992.

Abstract

Due to the urgent need for finding effective and free of secondary effect treatments for every clinical form of Leishmaniasis, a series of synthetic xylene, pyridine and, pyrazole azamacrocycles were tested against three Leishmania species. A total of 14 compounds were tested against J774.2 macrophage cells which were models for host cells, and against promastigote and amastigote forms of each studied Leishmania parasite. Amongst these polyamines, one proved effective against L. donovani, another one for L. braziliensis and L. infantum, and another one was selective solely for L. infantum. These compounds showed leishmanicidal activity and reduced parasite infectivity and dividing ability. Action mechanism studies gave a hint that compounds were active against Leishmania due to their ability to alter parasite metabolic pathways and reduce (except Py33333) parasitic Fe-SOD activity.

Keywords: Leishmania; SOD inhibition; chemotherapy; macrocycles; mechanism of action; pyrazole; pyridine.

Grants and funding

This research was funded by the Spanish Ministry for Science and Innovation and FEDER funds from the EU (grants PID2019-110751RB-I00 and CEX2019-000919) and the Conselleria de Innovación, Universidades, Ciencia y Sociedad Digital of the Generalitat Valenciana (PROMETEO Grant CIPROM/2021/030). This contribution is also based upon work from COST Action CA18202 and NECTAR—Network for Equilibria and Chemical Thermodynamics Advanced Research, supported by COST (European Cooperation in Science and Technology). Á.M.-M. is grateful to the European Union and Junta de Andalucía for a post-doc grant (Ayuda a la contratación de personal investigador doctor). Á.M.-C. wants to thank the Generalitat Valenciana and the ESF for the postdoc grant APOSTD/2020/065.